Physician
Kasgarli, Emel
Kasgarli, Emel was paid $0.00 by Medicaid between Sep 2020 and Jul 2024, across 39 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 0% of everything it billed.
33Billing provider infoKASGARLI, EMEL
PALMDALE, CA 93552
PALMDALE, CA 93552
33aNPI1922452382assigned 04/21/2016
33bProvider typeInternal Medicine Physician
28Total paid$0.00
24GClaims14,373
24DCodes billed39
24AFirst – last monthSep 2020 – Jul 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#2,431 of 2,679
Median peer was paid$13K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 425 | $0.00 | |
| 2021 | 1,988 | $0.00 | |
| 2022 | 3,675 | $0.00 | |
| 2023 | 4,419 | $0.00 | |
| 2024incomplete | 3,866 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 0% | 908 | 876 | $0.00 |
| 99441 | 0% | 386 | 359 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 156 | 155 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,026 | 939 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 1,464 | 1,457 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 583 | 578 | $0.00 |
| 85027 | 0% | 451 | 442 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 1,406 | 1,308 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 0% | 549 | 524 | $0.00 |
| 81001 | 0% | 25 | 25 | $0.00 | |
| 3044F | 0% | 138 | 137 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,848 | 2,563 | $0.00 |
27 more codes
| 81000 | 0% | 58 | $0.00 | |
| 1111F | 0% | 182 | $0.00 | |
| 82043 | 0% | 82 | $0.00 | |
| 3079F | 0% | 71 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 105 | $0.00 |
| 86780 | 0% | 82 | $0.00 | |
| 3075F | 0% | 29 | $0.00 | |
| 3074F | 0% | 254 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 13 | $0.00 |
| 90686 | 0% | 12 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 29 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 28 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 12 | $0.00 |
| 80061 | Lipid panel | 0% | 1,292 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 1,076 | $0.00 |
| 82540 | 0% | 82 | $0.00 | |
| 99442 | 0% | 366 | $0.00 | |
| 86703 | 0% | 246 | $0.00 | |
| 82274 | 0% | 38 | $0.00 | |
| 81025 | 0% | 12 | $0.00 | |
| 3077F | 0% | 28 | $0.00 | |
| 3078F | 0% | 256 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 13 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 28 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 13 | $0.00 |
| 81003 | 0% | 13 | $0.00 | |
| 84439 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.